IH Relative Valuation
IH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IH is overvalued; if below, it's undervalued.
Historical Valuation
iHuman Inc (IH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.23. The fair price of iHuman Inc (IH) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.56
Fair
9.10
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
iHuman Inc. (IH) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.00. The thresholds are as follows: Strongly Undervalued below -95.50, Undervalued between -95.50 and -48.25, Fairly Valued between 46.25 and -48.25, Overvalued between 46.25 and 93.50, and Strongly Overvalued above 93.50. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-1.12
EV/EBIT
iHuman Inc. (IH) has a current EV/EBIT of -1.12. The 5-year average EV/EBIT is -37.63. The thresholds are as follows: Strongly Undervalued below -551.06, Undervalued between -551.06 and -294.34, Fairly Valued between 219.09 and -294.34, Overvalued between 219.09 and 475.81, and Strongly Overvalued above 475.81. The current Forward EV/EBIT of -1.12 falls within the Historic Trend Line -Fairly Valued range.
0.77
PS
iHuman Inc. (IH) has a current PS of 0.77. The 5-year average PS is 1.48. The thresholds are as follows: Strongly Undervalued below -1.97, Undervalued between -1.97 and -0.25, Fairly Valued between 3.21 and -0.25, Overvalued between 3.21 and 4.93, and Strongly Overvalued above 4.93. The current Forward PS of 0.77 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
iHuman Inc. (IH) has a current P/OCF of 0.00. The 5-year average P/OCF is 1.03. The thresholds are as follows: Strongly Undervalued below -4.32, Undervalued between -4.32 and -1.64, Fairly Valued between 3.71 and -1.64, Overvalued between 3.71 and 6.38, and Strongly Overvalued above 6.38. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
iHuman Inc. (IH) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
iHuman Inc (IH) has a current Price-to-Book (P/B) ratio of 0.96. Compared to its 3-year average P/B ratio of 1.03 , the current P/B ratio is approximately -6.48% higher. Relative to its 5-year average P/B ratio of 1.31, the current P/B ratio is about -26.31% higher. iHuman Inc (IH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.15%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.09% , the current FCF yield is about -100.00% lower.
0.96
P/B
Median3y
1.03
Median5y
1.31
0.00
FCF Yield
Median3y
3.15
Median5y
2.09
Competitors Valuation Multiple
The average P/S ratio for IH's competitors is , providing a benchmark for relative valuation. iHuman Inc Corp (IH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -6.95%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IH increased by 51.48% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 11.47 to 15.93.
The secondary factor is the P/E Change, contributed 19.55%to the performance.
Overall, the performance of IH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is iHuman Inc (IH) currently overvalued or undervalued?
What is iHuman Inc (IH) fair value?
How does IH's valuation metrics compare to the industry average?
What is the current P/B ratio for iHuman Inc (IH) as of Dec 05 2025?
What is the current FCF Yield for iHuman Inc (IH) as of Dec 05 2025?
What is the current Forward P/E ratio for iHuman Inc (IH) as of Dec 05 2025?